Evidence map›Paper›PMID 19711440›Full record

Trial reportClinical cardiology2009

Systolic blood pressure and subjective well-being in patients with coronary artery disease.

Yan Gong, Eileen M Handberg, Tobias Gerhard, Rhonda M Cooper-Dehoff, L Douglas Ried, Julie A Johnson, Carl J Pepine, INVEST Investigators

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Clinical cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00133692 (INternational VErapamil SR Trandolapril STudy), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00133692 phase4completednot on this map

INternational VErapamil SR Trandolapril STudy

TypeinterventionalSponsorUniversity of FloridaRan1997 to 2003Enrolled22,000ConditionsHypertension, Coronary Artery DiseaseArmsVerapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ), Atenolol/HCTZ/Trandolapril
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Measuring subjective wellbeing in patients with heart disease: relationship and comparison between health-related quality of life instruments.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  9. Article
  10. Quality of Life in Treatment-Resistant Hypertension.Current hypertension reports · 2015
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yan GongCollege of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Eileen M Handberg
Tobias Gerhard
Rhonda M Cooper-Dehoff
L Douglas Ried
Julie A Johnson
Carl J Pepine
INVEST Investigators
University of Florida · USMalcom Randall VA Medical Center · US

Funding

Metabolic Effects of Antihypertensive DrugsK23HL086558 · NHLBI · UNIVERSITY OF FLORIDA · PI COOPER-DEHOFF, RHONDA M · 2007 to 2011
$672k
NHLBI NIH HHS 1K23HL086558NHLBI NIH HHS K23 HL086558
6 · The paper itself

Abstract

backgroundLimited information exists regarding the association between subjective well-being (SWB) and systolic blood pressure (SBP) among hypertensive patients with coronary artery disease (CAD). HYPOTHESIS: We tested the hypothesis that there is an association between SBP and SWB.

methodsWe studied 22,576 hypertensive CAD patients > or = 50 years old in the INternational VErapamil SR-Trandolapril Study (INVEST), a randomized, blinded-endpoint trial of antihypertensive therapy in stable CAD patients. At each study visit, patients rated their SWB in the previous 4 weeks as "excellent," "good," "fair," or "poor" prior to SBP recordings. The outcome measure was SWB of "fair" or "poor." A longitudinal analysis using generalized estimating equations was performed to assess the association between SBP and odds of reporting fair/poor SWB, controlling for baseline SWB of fair/poor and angina reported during the study.

resultsPatients with higher SBP had higher odds of reporting fair/poor SWB. Specifically, compared with patients with SBP of < or = 120, patients with SBP 140-150 > 150 - < or = 160 and > 160 had about 90% and 2.5 times greater odds of feeling fair/poor, respectively (adjusted odds ratio [OR]: 1.5990, 95% confidence interval [CI]: 1.81-2.00 and adjusted OR: 2.53, 95% CI: 2.41-2.66). Those who reported angina in the 4 wks prior to a protocol visit had 2.2 times greater odds of reporting fair/poor SWB (adjusted OR: 2.2, 95% CI: 2.13-2.27). Female gender, black race, history of smoking, diabetes, myocardial infarction, stroke, and cancer also increased the odds of reporting fair/poor SWB.

conclusionsAmong hypertensive CAD patients, higher on-treatment SBP is associated with greater odds of fair/poor SWB during follow-up.

Indexed as

Mental HealthQuality of LifeAgedAntihypertensive AgentsAtenololBlood PressureCoronary Artery DiseaseDrug Therapy, CombinationFemaleHumansHypertensionIndolesMaleMiddle AgedOdds RatioRisk AssessmentAntihypertensive AgentsAtenololIndolestrandolaprilVerapamil

Identifiers

PMID19711440
PMCPMC2810952
OpenAlexW2015611620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.